NCT07369986: Immunotherapy for Surgery Avoidance in Vulnerable dMMR Endometrial Cancer
- State
- Not started
- Phase
- Phase 2
- People
- 30 planned
- Started
- 1 Mar 2026
- Primary completion
- 31 Dec 2027
- Arms
- Immunotherapy
- Results
- None posted
- 27 Jan 2026: Trial registered